Balance Sheet for BGLC - findataslice

	BioNexus Gene Lab Corp (BGLC)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date			2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31	2023-Sep-30	2023-Jun-30	2023-Mar-31	2022-Dec-31	2022-Sep-30	2022-Jun-30	2022-Mar-31	2021-Dec-31	2021-Sep-30	2021-Jun-30	2021-Mar-31	2020-Dec-31	2020-Sep-30	2020-Jun-30	2020-Mar-31	2019-Dec-31	2019-Sep-30	2019-Jun-30	2019-Mar-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023	Q3-FY2023	Q2-FY2023	Q1-FY2023	Q4-FY2022	Q3-FY2022	Q2-FY2022	Q1-FY2022	Q4-FY2021	Q3-FY2021	Q2-FY2021	Q1-FY2021	Q4-FY2020	Q3-FY2020	Q2-FY2020	Q1-FY2020	Q4-FY2019	Q3-FY2019	Q2-FY2019	Q1-FY2019
Total Assets			9,252,784$	7,621,228$	9,421,205$	9,479,939$	10,433,848$	10,995,055$	11,139,727$	11,161,483$	11,399,793$	11,465,522$	7,898,940$	8,186,641$	8,740,162$	7,798,236$	8,368,713$	9,175,422$	9,574,390$	9,765,004$	9,448,123$	9,898,531$	10,115,293$	1,013,219$	1,060,241$	1,126,915$	1,231,236$	1,344,403$	1,512,903$	1,607,160$	1,652,239$
Total Current Assets			5,448,738$	5,626,802$	6,379,326$	6,542,389$	7,430,449$	7,039,453$	7,842,869$	7,905,437$	8,046,800$	8,269,827$	5,226,749$	5,458,763$	6,021,826$	5,408,975$	5,766,167$	6,601,091$	7,149,855$	7,402,248$	7,098,570$	7,563,071$	7,985,494$	720,215$	762,753$	808,074$	882,571$	1,016,281$	1,170,778$	1,249,788$	1,298,354$
Cash and Cash Equivalents			2,486,383$				2,886,966$											1,844,322$	2,123,919$	1,700,396$	1,482,705$	2,474,659$	2,787,692$	2,190,072$	1,287,111$	1,396,747$	859,076$	977,149$	1,140,387$		1,260,239$	1,416,242$
Receivables
Other Current Assets			83,333$
Assets Held for Sale in Short Term
Total Noncurrent Assets			3,804,046$	1,994,426$	3,041,879$	2,937,550$	3,003,399$	3,955,602$	3,296,858$	3,256,046$	3,352,993$	3,195,695$	2,672,191$	2,727,878$	2,718,336$	2,389,261$	2,602,546$	2,574,331$	2,424,535$	2,362,756$	2,349,553$	2,335,460$	2,129,799$	293,004$	297,488$	318,841$	348,665$	328,122$	342,125$	357,372$	353,885$
Goodwill
Other Intangible Assets
Physical Assets			1,598,769$	1,570,584$	1,592,907$	1,520,279$	1,522,990$	1,728,680$	1,347,600$	1,471,638$	1,511,618$	1,496,562$	1,396,621$	1,481,767$	1,511,708$	1,440,303$	1,533,331$	1,628,341$	1,634,418$	1,647,359$	1,683,566$	1,708,104$	1,785,602$	276,866$	279,018$	287,625$	312,908$	316,182$	330,055$	345,122$	341,805$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities			637,856$	804,966$	1,899,168$	1,708,303$	2,111,044$	1,606,882$	1,593,973$	1,817,296$	1,741,941$	1,777,807$	1,935,174$	1,629,733$	2,075,149$	1,374,582$	1,547,066$	2,047,353$	2,394,611$	2,713,398$	2,634,899$	3,106,101$	3,453,139$	81,629$	90,558$	94,181$	108,872$	80,626$	123,297$	129,556$	130,313$
Total Current Liabilities			520,957$	678,023$	1,757,821$	1,560,363$	1,951,303$	1,414,869$	1,399,358$	1,716,534$	1,630,923$	1,644,060$	1,876,469$	1,563,379$	2,004,077$	1,334,923$	1,502,524$	1,984,703$	2,328,755$	2,664,823$	2,575,793$	3,035,429$	3,373,598$	38,163$	46,452$	47,355$	51,574$	27,099$	64,168$	66,182$	62,893$
Accounts Payable						1,182,723$	1,503,326$	1,033,125$	954,785$	1,429,162$	1,402,180$	1,569,992$	1,822,506$	1,493,774$	1,861,015$	1,278,699$	1,416,198$	1,834,294$	2,012,266$
Short Term Debt
Short Term Capital Lease Obligations			59,147$	56,803$	55,809$	52,173$	50,816$	48,214$	53,210$	32,508$	34,632$	33,897$	16,098$	16,733$	16,569$	11,782$	14,034$	16,412$	18,272$	18,566$	18,472$	16,793$	20,702$	11,152$	11,540$		11,936$
Other Current Liabilities
Total Noncurrent Liabilities			116,899$	126,943$	141,347$	147,940$	159,741$	192,013$	194,615$	100,762$	111,018$	133,747$	58,705$	66,354$	71,072$	39,659$	44,542$	62,650$	65,856$	48,575$	59,106$	70,672$	79,541$	43,466$	44,106$	46,826$	57,298$	53,527$	59,129$	63,374$	67,420$
Long Term Debt
Long Term Capital Lease Obligations			116,899$	126,943$	141,347$	147,940$	159,741$	178,367$	182,697$	88,846$	98,763$	104,867$	29,658$	35,676$	40,206$	14,118$	17,692$	21,489$	24,637$	28,676$	33,685$	39,911$	42,377$	3,966$	5,740$	8,657$	12,212$
Other Noncurrent Liabilities
Total Equity			8,614,928$	6,816,262$	7,522,037$	7,771,636$	8,322,804$	9,388,173$	9,545,754$	9,344,187$	9,657,852$	9,316,088$	5,592,139$	6,185,281$	6,665,013$	6,423,654$	6,821,647$	7,128,069$	7,179,779$	7,051,606$	6,813,224$	6,792,430$	6,662,154$	6,682,462$	6,199,934$	1,122,364$	1,122,364$	1,263,777$	1,389,606$	1,477,604$	1,521,926$			94,626$
Equity to Minority
Equity to Common Shareholders			8,614,928$	6,816,262$	7,522,037$	7,771,636$	8,322,804$	9,388,173$	9,545,754$	9,344,187$	9,657,852$	9,316,088$	5,592,139$	6,185,281$	6,665,013$	6,423,654$	6,821,647$	7,128,069$	7,179,779$	7,051,606$	6,813,224$	6,792,430$	6,662,154$	6,682,462$	6,199,934$	1,122,364$	1,122,364$	1,263,777$	1,389,606$	1,477,604$	1,521,926$			94,626$
Additional Paid-In Capital			(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)	(5,011,891$)
Retained Earnings			(6,427,227$)	(5,391,110$)	(4,682,119$)	(4,065,947$)	(3,442,620$)	(3,094,301$)	(1,748,931$)	(1,948,035$)	(1,844,278$)	(1,781,114$)	828,075$	1,087,326$	1,156,392$	1,313,361$	1,390,762$	1,529,424$	1,512,358$	1,423,115$	1,127,793$	1,099,531$	760,787$	(507,836$)	(447,801$)	(381,264$)	(333,311$)	(240,734$)	(218,707$)		(86,842$)
Treasury Stock
Capital Lease Obligations			176,046$	183,746$	197,156$	200,113$	210,557$	25,337$			133,395$